Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Insulet Collaborates with Samsung to Deliver Galaxy Smartphone-Controlled Insulin Pump Delivery System
Incorporates Best-In-Class Cyber-Security Protocols and Mobile App Controlled Omnipod BILLERICA, Mass. --(BUSINESS WIRE)--Nov. 7, 2018-- Insulet Corporation  (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ®  Insulin Management System (Omnipod
View HTML
Toggle Summary Insulet Raises Awareness for National Diabetes Awareness Month
Highlights Include Beyond Type Run Team NYC Marathon Sponsorship, NASDAQ Closing Bell Ceremony and Global Fundraising Events BILLERICA, Mass. --(BUSINESS WIRE)--Nov. 5, 2018-- Insulet Corporation  (NASDAQ:PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ®
View HTML
Toggle Summary Insulet Reports Third Quarter 2018 Revenue of $151.1 Million, Up 24% Year-Over-Year, and Gross Margin Over 67%, Up 700 Basis Points
Achieved Both Positive Operating and Net Income for the First Time in Insulet's History BILLERICA, Mass. --(BUSINESS WIRE)--Nov. 1, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System
View HTML
Toggle Summary Omnipod® Insulin Management System Now Available for Use in Europe with Fiasp® Fast-Acting Insulin
Omnipod System to be Highlighted at the 54 th Annual Meeting of the European Association for the Study of Diabetes in Berlin, Germany LONDON --(BUSINESS WIRE)--Oct. 2, 2018-- Insulet Corporation  (NASDAQ: PODD) (Insulet or the Company), the global leader in  tubeless insulin pump technology with
View HTML
Toggle Summary Insulet to Announce Third Quarter 2018 Financial Results on November 1, 2018
BILLERICA, Mass. --(BUSINESS WIRE)--Sep. 24, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the third quarter of 2018
View HTML
Toggle Summary Insulet Announces Shacey Petrovic, President and COO, Promoted to CEO, Effective January 1, 2019; Patrick Sullivan Will Retire as Chairman and CEO at the End of 2018
Timothy Scannell Will Become Chairman of the Board BILLERICA, Mass. --(BUSINESS WIRE)--Sep. 10, 2018-- Insulet Corporation  (NASDAQ: PODD) (Insulet or the Company), the global leader in  tubeless insulin pump technology with its Omnipod ®  Insulin Management System (Omnipod System), today announced
View HTML
Toggle Summary Insulet to Present at Upcoming Investor Conferences
BILLERICA, Mass. --(BUSINESS WIRE)--Aug. 28, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two upcoming investor conferences in New York City
View HTML
Toggle Summary Insulet to Showcase Its Omnipod DASH™ Insulin Management System at the American Association of Diabetes Educators Annual Conference
BILLERICA, Mass. --(BUSINESS WIRE)--Aug. 16, 2018-- Insulet Corporation  (NASDAQ: PODD) (Insulet or the Company), the global leader in  tubeless insulin pump technology with its Omnipod ®  Insulin Management System (Omnipod System), today announced it will showcase its recently FDA cleared Omnipod
View HTML
Toggle Summary Insulet Reports Second Quarter 2018 Revenue of $124.3 Million, Up 13% Year-Over-Year, and Gross Margin of 66%, Up 710 Basis Points
Full Year 2018 Expected Revenue Growth Revised to 18% to 21% Third Quarter Expected Revenue Growth of 19% to 24% BILLERICA, Mass. --(BUSINESS WIRE)--Aug. 2, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ®
View HTML
Toggle Summary Insulet Extends Partnership with Glooko in Europe to Optimise Diabetes Data Management
LONDON --(BUSINESS WIRE)--Jul. 12, 2018-- Insulet Corporation  (NASDAQ: PODD) (Insulet or the Company), the global leader in  tubeless insulin pump  technology with its Omnipod ®  Insulin Management System (Omnipod System), today announced that it has partnered with Glooko ® , Inc.
View HTML
Toggle Summary Insulet to Announce Second Quarter 2018 Financial Results on August 2, 2018
BILLERICA, Mass. --(BUSINESS WIRE)--Jul. 11, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the second quarter of 2018
View HTML
Toggle Summary Insulet Partners with the International Diabetes Federation Europe to Support Advocacy Activities Across the Continent
BILLERICA, Mass. & LONDON --(BUSINESS WIRE)--Jul. 9, 2018-- Insulet Corporation  (NASDAQ: PODD) (Insulet or the Company), the global leader in  tubeless insulin pump  technology with its Omnipod ®  Insulin Management System (Omnipod System), today announced it has entered into a partnership with
View HTML
Toggle Summary Omnipod® Insulin Management System Now the Preferred Insulin Pump in British Columbia, Canada
Tubeless, Waterproof * Insulin Pump and Wireless, Handheld Personal Diabetes Manager Make Switching from Multiple Daily Injections to Pump Therapy Much Easier BILLERICA, Mass. & ONTARIO, Canada --(BUSINESS WIRE)--Jul. 3, 2018-- Insulet Corporation  (NASDAQ: PODD) (Insulet or the Company), the
View HTML
Toggle Summary Insulet Assumes Direct Operations of its Omnipod® Insulin Management System Product Line in Europe
BILLERICA, Mass. & LONDON --(BUSINESS WIRE)--Jul. 2, 2018-- Insulet Corporation  (NASDAQ: PODD) (Insulet or the Company), the leader in  tubeless insulin pump  technology with its Omnipod ®  Insulin Management System (Omnipod System), today announced as of July 1 , it has assumed direct commercial
View HTML
Toggle Summary Insulet Presents Positive Clinical Trial Results for the Omnipod® Horizon™ Hybrid Closed-Loop System at the American Diabetes Association's 78th Scientific Sessions
Omnipod ® Horizon ™ System Significantly Improves Glycemic Control in Patients with Type 1 Diabetes BILLERICA, Mass. --(BUSINESS WIRE)--Jun. 24, 2018-- Insulet Corporation  (NASDAQ:PODD) (Insulet or the Company), the leader in  tubeless insulin pump technology with its Omnipod ®  Insulin Management
View HTML